Visitor information – Everything you need to know about visiting our sites.
We provide clinical haematology, stem cell transplant and haemophilia services to all adults in Victoria with a disease of the blood or bone marrow.
Our laboratory and clinical research is conducted as part of the Australian Centre for Blood Diseases (ACBD).
We are a multidisciplinary team who specialise in the diagnosis, treatment and follow up of the entire range of diseases and disorders related to the blood.
Malignant Haematology, Transplantation and Cellular Therapies
The Malignant Haematology, Transplantation and Cellular Therapies Service cares for patients throughout Victoria with blood cancers.
CAR-T Cell Therapy
Chimeric antigen receptor T cell therapy (CAR-T) is a new treatment for certain types of blood cancers that uses a person’s own immune cells (T cells) to try to destroy cancer cells.
Haemophilia & Bleeding Disorders
We strive to improve the quality of life of patients affected by haemophilia and other bleeding disorders through individualised treatment including diagnosis, consultancy and ongoing care for adults with an inherited bleeding disorder.
Research groups
- Acute Leukaemia Research Group
- Acute Myeloid Leukaemia Research Group
- Stem Cell Biology Group
- Mammalian Functional Genetics Unit
- Molecular Neurotrauma and Haemostasis Unit
- Leukaemia Signalling Pathways Group
- Myeloma Research Group
- Systems Haematology Unit
- Vascular Biology Group
- NanoBiotechnology Group
- Platelets and Thrombosis Laboratory
Latest news
New treatment option for older patients with blood cancer
Researchers are a step closer to offering older patients with an aggressive blood cancer, acute myeloid leukaemia (AML), a new less-toxic treatment option.
Blood clot removal surgery saving lives
A complex surgery to remove chronic blood clots from arteries in the lungs is giving Australians and New Zealanders a second chance.
New centre dedicated to blood cancer research
The Alfred and Monash University are set to establish Australia’s first dedicated blood cancer research centre, thanks to a $1.2 million grant from the Australian Cancer Research Foundation (ACRF).